Dr. Roger Niles Pearse MD
Oncologist | Medical Oncology
520 E 70th St # Starr-341 New York NY, 10021About
Dr. Roger Pearse is an oncologist practicing in New York, NY. Dr. Pearse specializes in the care and treatment of patients with cancer. As an oncologist, Dr. Pearse manages and oversees the treatment of a cancer patient after he or she has been diagnosed with the disease. Oncologists will care for their patients throughout the course of the disease. Types of oncologists include medical oncologists, surgical oncologists, radiation oncologists, gynecologic oncologists, pediatric oncologists and hematologist oncologists.
Board Certification
Internal MedicineAmerican Board of Internal MedicineABIM- Hematology
Provider Details
Expert Publications
Data provided by the National Library of Medicine- SHIP recruitment attenuates Fc gamma RIIB-induced B cell apoptosis.
- Myeloma interacts with the bone marrow microenvironment to induce osteoclastogenesis and is dependent on osteoclast activity.
- RANK-Fc: a therapeutic antagonist for RANK-L in myeloma.
- Wnt antagonism in multiple myeloma: a potential cause of uncoupled bone remodeling.
- Lenalidomide-induced myelosuppression is associated with renal dysfunction: adverse events evaluation of treatment-naïve patients undergoing front-line lenalidomide and dexamethasone therapy.
- New strategies for the treatment of metastatic bone disease.
- Characterization of the promoter of the human gene encoding the high-affinity IgG receptor: transcriptional induction by gamma-interferon is mediated through common DNA response elements.
- Autologous stem cell transplant is feasible in very elderly patients with lymphoma and limited comorbidity.
- Age matters: Young T lymphocytes offer better protection from myeloma proliferation.
- IMiDs: Not for the CRBN weak.
- Thalidomide, clarithromycin, lenalidomide and dexamethasone therapy in newly diagnosed, symptomatic multiple myeloma.
- Prognostic biomarkers for renal amyloid.
- PU.1 and an HLH family member contribute to the myeloid-specific transcription of the Fc gamma RIIIA promoter.
- SHIP modulates immune receptor responses by regulating membrane association of Btk.
Fellowships
- Memorial Sloan - Kettering Cancer Center
Dr. Roger Niles Pearse MD's Practice location
Dr. Roger Niles Pearse MD's reviews
Write ReviewRecommended Articles
- What Specialists Treat Testicular Cancer?
The type of cancer that affected the male sex organs, particularly the male gonads called the testes, was regarded as an incurable condition back in the 70s. Since then, advanced diagnostic tools, exceptional treatment methods, and refined therapies have elevated testicular cancer to the status of a...
- Why Ovarian Cancer is Difficult to Detect Early
All too often we hear the term “the silent killer” when describing ovarian cancer. This term has come from the false belief that ovarian cancer is a disease without any warning signs and without much research. However, there is quite a lot of research, in fact, that confirms that most women who...
- Chlamydia Doubled Ovarian Cancer Risk, Study Shows
Chlamydia trachomatis, commonly known as chlamydia, is a type of sexually transmitted infection (STI). In the United States, approximately 1.5 million cases of chlamydia are reported on an annual basis, making it the most commonly reported type of bacterial infection – according to the Centers for...
- Can Testicular Cancer be Fatal?
Testicular cancer is the appearance of a painless lump that represents an aggregation of testicular tissue which continues to divide seemingly without any control. What provokes testicular cells to behave abnormally is still in the realm of speculation, and most specialists veer to the opinion that...
- Diem Brown is Remembered with Every New MTV 'Challenge' Season
Many fell in love with Diem Brown during her season of MTV's 'The Challenge' but sadly, she passed away only a few weeks after the show from her battle with cancer. However, MTV has put in place a way to ensure that she is remembered for seasons to come.Remembering DiemAfter the show finished...
- NHS Strikes Deal for Cutting Edge Cancer Treatment for Adults with Lymphoma
The National Health Service (NHS) is the publicly-funded national healthcare system for England. Together with the biopharmaceutical company, Gilead Sciences, the two organizations have reached an agreement to provide CAR T-cell therapy to patients with a type of cancer that has, sadly, left them...
Nearby Providers
- Dr. Maria Theodoulou MD1275 York Ave New York NY 10021
- Dr. Richard Carvajal M.D.1275 York Ave New York NY 10021
- Dr. Mark Frattini MD1275 York Ave New York NY 10021
- Dr. Craig Moskowitz MD1275 York Ave New York NY 10021
- Dr. Andrew Zalenetz MD1275 York Ave New York NY 10021
- Dr. Emil Lou M.D., PH.D1275 York Avenue New York NY 10021